Get the updates in your inbox
Subscribe to get the latest news and updates.
No spam. We promise.
The UPC is set to launch in Europe while legislators in the United States tackle the risks and opportunities of generative AI.
Though Intellectual Property (IP) disputes are not uncommon in the pharmaceutical industry, the scale and prominence of this litigation are of rare magnitude.
A decades-long saga about the POLO brand and what it means to consumers in South Africa saw its most recent play.
The Dennemeyer Group is honored to be cited once again in the latest release of the World Trademark Review (WTR) 1000.